As of 2024-12-14, the Relative Valuation of Karuna Therapeutics Inc (KRTX) is (203.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 329.83 USD, the upside of Karuna Therapeutics Inc based on Relative Valuation is -161.7%.
The range of the Relative Valuation is (126.18) - (214.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.4x - 24.1x | 17.3x |
| Forward P/E multiples | 11.1x - 18.9x | 18.5x |
| Fair Price | (126.18) - (214.39) | (203.48) |
| Upside | -138.3% - -165.0% | -161.7% |
| Date | P/E |